Evidence map›Paper›PMID 31517483›Full record

ArticleACS applied materials & interfaces2019

Triple PLGA/PCL Scaffold Modification Including Silver Impregnation, Collagen Coating, and Electrospinning Significantly Improve Biocompatibility, Antimicrobial, and Osteogenic Properties for Orofacial Tissue Regeneration.

Yunzhu Qian, Xuefeng Zhou, Feimin Zhang, Thomas G H Diekwisch, Xianghong Luan, Jianxin Yang

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 223 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. ACS omega · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Yunzhu QianCenter of Stomatology , The Second Affiliated Hospital of Soochow University , Suzhou 215004 , People's Republic of China.
Xuefeng ZhouState Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering , Southeast University , Nanjing 210096 , People's Republic of China.
Feimin ZhangJiangsu Key Laboratory of Oral Diseases , Nanjing Medical University , Nanjing 210029 , People's Republic of China.ORCID http://orcid.org/0000-0003-3833-8923
Thomas G H DiekwischTexas A&M Center for Craniofacial Research and Diagnosis , Dallas , Texas 75246 , United States.ORCID http://orcid.org/0000-0003-3356-9677
Xianghong LuanTexas A&M Center for Craniofacial Research and Diagnosis , Dallas , Texas 75246 , United States.
Jianxin YangCenter of Stomatology , The Second Affiliated Hospital of Soochow University , Suzhou 215004 , People's Republic of China.ORCID http://orcid.org/0000-0003-4750-2174
International Craniofacial Institute · USSoochow University · CNNanjing Medical University · CNState Key Laboratory of Digital Medical Engineering

Funding

Small Molecule Microenvironment Design for Craniofacial Bone Regeneration and EngineeringR01DE019463 · NIDCR · UNIVERSITY OF ROCHESTER · PI LUAN, XIANGHONG · 2009 to 2021
$2.8M
Neurological control of periodontal homeostasis through microRNA, TGF-beta, and Wnt signalingR01DE027930 · NIDCR · UNIVERSITY OF ROCHESTER · PI DIEKWISCH, TOM · 2018 to 2022
$1.8M
Small molecule mediated restoration of periodontal homeostasis through the YAP1 pathwayR01DE026198 · NIDCR · UNIVERSITY OF ROCHESTER · PI DIEKWISCH, TOM · 2017 to 2021
$1.7M
NIDCR NIH HHS R01 DE019463NIDCR NIH HHS R01 DE026198NIDCR NIH HHS R01 DE027930
6 · The paper itself

Abstract

Biodegradable synthetic scaffolds hold great promise for oral and craniofacial guided tissue regeneration and bone regeneration. To overcome the limitations of current scaffold materials in terms of osteogenic and antimicrobial properties, we have developed a novel silver-modified/collagen-coated electrospun poly-lactic-co-glycolic acid/polycaprolactone (PLGA/PCL) scaffold (PP-pDA-Ag-COL) with improved antimicrobial and osteogenic properties. Our novel scaffold was generated by electrospinning a basic PLGA/PCL matrix, followed by silver nanoparticles (AgNPs) impregnation via in situ reduction, polydopamine coating, and then coating by collagen I. The three intermediate materials involved in the fabrication of our scaffolds, namely, PLGA/PCL (PP), PLGA/PCL-polydopamine (PP-pDA), and PLGA/PCL-polydopamine-Ag (PP-pDA-Ag), were used as control scaffolds. Scanning electron micrographs and mechanical testing indicated that the unique three-dimensional structures with randomly oriented nanofibrous electrospun scaffold architectures, the elasticity modulus, and the tensile strength were maintained after modifications. CCK-8 cell proliferation analysis demonstrated that the PP-pDA-Ag-COL scaffold was associated with higher MC3T3 proliferation rates than the three control scaffolds employed. Scanning electron and fluorescence light microscopy illustrated that PP-pDA-Ag-COL scaffolds significantly enhanced MC3T3 cell adhesion compared to the control scaffolds after 12 and 24 h culture, in tandem with the highest β1 integrin expression levels, both at the mRNA level and the protein level. Alkaline phosphatase activity, BMP2, and RUNX2 expression levels of MC3T3 cells cultured on PP-pDA-Ag-COL scaffolds for 7 and 14 days were also significantly higher when compared to controls (

Indexed as

Anti-Bacterial AgentsCoated Materials, BiocompatibleMaterials TestingAnimalsBone RegenerationCell LineCollagenDisease Models, AnimalGuided Tissue RegenerationMiceOsteogenesisPeriodontitisPolyestersPolylactic Acid-Polyglycolic Acid CopolymerSilverStaphylococcus aureusAnti-Bacterial AgentsCoated Materials, BiocompatibleCollagenpolycaprolactonePolyestersPolylactic Acid-Polyglycolic Acid CopolymerSilverantimicrobialbiomimetic scaffoldselectrospinninglocal deliveryosteogenicsilver nanoparticle

Identifiers

PMID31517483
PMCPMC7220812
OpenAlexW2972629861

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.